Memorial Sloan Kettering Cancer Center - Company Profile
Powered by
All the data and insights you need on Memorial Sloan Kettering Cancer Center in one report.
- Save hours of research time and resources with
our up-to-date Memorial Sloan Kettering Cancer Center Strategy Report
- Understand Memorial Sloan Kettering Cancer Center position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Memorial Sloan Kettering Cancer Center (MSKCC) is a healthcare service provider that offers cancer treatment, cancer research, and cancer education programs. It offers services such as research, education services, clinical trials, training services among others. The center conducts research in the therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeutics and drug development, cell biology, cell cycle regulation, cell death, cell signaling, immunology, genetics and genomics, molecular imaging and tumor growth. It offers various cancer types such as AIDS-associated cancers acoustic neuroma, adrenal tumors, anal cancer, appendiceal cancer, basal cell carcinoma, benign blood disorders, bile duct cancer, bladder cancer, bone cancer among others. The center also offers predoctoral and postdoctoral training. It has operations in New York and New Jersey, the US. MSKCC is headquartered in New York, the US.
Memorial Sloan Kettering Cancer Center premium industry data and analytics
Products and Services
Services |
---|
Education |
Research |
Training |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In August, the company and AI MEDICAL SERVICE INC. signed a joint research agreement in the field of gastrointestinal endoscopy AI. |
2022 | Contracts/Agreements | In November, the company entered into an agreement with Curbside Health to improve clinical oncology pathways. |
2022 | Contracts/Agreements | In July, the company entered a three-year research collaboration agreement with NeoPhore Limited to determine the potential of NeoPhore's proprietary DNA mismatch repair inhibitor compounds to enhance tumour immunogenicity and induce tumour immunity. |
Competitor Comparison
Key Parameters | Memorial Sloan Kettering Cancer Center | Abramson Cancer Center | Barrett Cancer Center | Radiotherapy Clinics of Georgia LLC | The Center for Mind-Body Medicine |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | New York City | Philadelphia | Cincinnati | Conyers | Washington |
State/Province | New York | Pennsylvania | Ohio | Georgia | WashingtonD.C. |
No. of Employees | - | - | - | - | - |
Entity Type | Institution | Institution | Institution | Institution | Institution |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Selwyn M. Vickers | Chief Executive Officer; President | Senior Management | - | - |
Michael P. Harrington | Executive Vice President; Chief Financial Officer | Senior Management | - | - |
Anaeze Offodile | Chief Strategy Officer | Senior Management | - | - |
Erin McDonough | Chief Communications Officer; Senior Vice President; Chief Marketing Officer | Senior Management | - | - |
LaKisha Mack | Chief Administrative Officer | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer